FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1230114009: Product containing bacitracin and neomycin and sulfacetamide (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5067236011 Bacitracin- and neomycin- and sulfacetamide-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5067237019 Product containing bacitracin and neomycin and sulfacetamide (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bacitracin- and neomycin- and sulfacetamide-containing product Is a Product containing sulfacetamide (medicinal product) true Inferred relationship Some
Bacitracin- and neomycin- and sulfacetamide-containing product Is a Product containing bacitracin (medicinal product) true Inferred relationship Some
Bacitracin- and neomycin- and sulfacetamide-containing product Is a Product containing neomycin (medicinal product) true Inferred relationship Some
Bacitracin- and neomycin- and sulfacetamide-containing product Plays role Antibacterial therapeutic role (role) false Inferred relationship Some
Bacitracin- and neomycin- and sulfacetamide-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sulfacetamide (substance) true Inferred relationship Some 1
Bacitracin- and neomycin- and sulfacetamide-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin (substance) true Inferred relationship Some 2
Bacitracin- and neomycin- and sulfacetamide-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bacitracin true Inferred relationship Some 3
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only bacitracin and neomycin and sulfacetamide (medicinal product) Is a True Bacitracin- and neomycin- and sulfacetamide-containing product Inferred relationship Some
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form Is a True Bacitracin- and neomycin- and sulfacetamide-containing product Inferred relationship Some

Reference Sets

Description inactivation indicator reference set

Back to Start